Case Report
BibTex RIS Cite

Cystic fibrosis diagnosed in a nineteen-year-old case

Year 2023, Volume: 9 Issue: 6 - November 2023, 1537 - 1540, 04.11.2023
https://doi.org/10.18621/eurj.1207253

Abstract

Cystic fibrosis is the most common autosomal recessive hereditary disease in white populations. It is characterized by the formation of abnormal secretions in the exocrine glands located in the sweat and salivary glands, tracheobronchial tree, large intestine, and pancreas. The severity of the clinic depends on the type of "cystic fibrosis transmembrane regulatory protein" gene mutation. Although most cases are diagnosed in infancy or childhood, some patients are also diagnosed during adolescence and adulthood. We report a case of a 19-year-old patient who was followed up with a diagnosis of asthma and bronchiectasis since childhood and diagnosed with cystic fibrosis.

References

  • 1. Katkin JP. Cystic fibrosis: clinical manifestations and diagnosis. UptoDate, March 2023. Online. https://www.uptodate.com/contents/cystic-fibrosis-clinical-manifestations-and-diagnosis
  • 2. Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003;9:498-503.
  • 3. Burgel PR, Fajac I. Cystic fibrosis: current aspects and perspectives. Presse Med 2017;46(6 Pt 2):e85-6.
  • 4. Yıldırım E, İntepe YS, Çiftçi B. [Adult cystic fibrosis: A case report]. Turk J Clin Lab 2018;9:353-6. [Article in Turkish]
  • 5. Üstü Y, Uğurlu M. [National early diagnosis and screening program: cystic fibrosis]. Ankara Med J 2016;16:239-41. [Article in Turkish]
  • 6. Turcios NL. Cystic fibrosis lung disease: an overview. Respir Care 2020;65:233-51.
  • 7. Becq F, Mirval S, Carrez T, Lévêque M, Billet A, Coraux C, et al. The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor. Eur Respir J 2022;59:2100671.
Year 2023, Volume: 9 Issue: 6 - November 2023, 1537 - 1540, 04.11.2023
https://doi.org/10.18621/eurj.1207253

Abstract

References

  • 1. Katkin JP. Cystic fibrosis: clinical manifestations and diagnosis. UptoDate, March 2023. Online. https://www.uptodate.com/contents/cystic-fibrosis-clinical-manifestations-and-diagnosis
  • 2. Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003;9:498-503.
  • 3. Burgel PR, Fajac I. Cystic fibrosis: current aspects and perspectives. Presse Med 2017;46(6 Pt 2):e85-6.
  • 4. Yıldırım E, İntepe YS, Çiftçi B. [Adult cystic fibrosis: A case report]. Turk J Clin Lab 2018;9:353-6. [Article in Turkish]
  • 5. Üstü Y, Uğurlu M. [National early diagnosis and screening program: cystic fibrosis]. Ankara Med J 2016;16:239-41. [Article in Turkish]
  • 6. Turcios NL. Cystic fibrosis lung disease: an overview. Respir Care 2020;65:233-51.
  • 7. Becq F, Mirval S, Carrez T, Lévêque M, Billet A, Coraux C, et al. The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor. Eur Respir J 2022;59:2100671.
There are 7 citations in total.

Details

Primary Language English
Subjects Respiratory Diseases
Journal Section Case Reports
Authors

Meltem Yılmaz 0000-0003-0314-4774

Levent Mutlu 0000-0002-3535-5704

Early Pub Date May 29, 2023
Publication Date November 4, 2023
Submission Date November 19, 2022
Acceptance Date April 8, 2023
Published in Issue Year 2023 Volume: 9 Issue: 6 - November 2023

Cite

AMA Yılmaz M, Mutlu L. Cystic fibrosis diagnosed in a nineteen-year-old case. Eur Res J. November 2023;9(6):1537-1540. doi:10.18621/eurj.1207253

e-ISSN: 2149-3189 


The European Research Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png

2024